Delivery Order SPE2DB22D2206-SPE2DB24FHM85
- Not listed
- This federal contract award, valued at $14,536.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566598452 REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of December 4, 2024 and is a Firm Fixed Price arrangement. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award, valued at $5,137.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of REMICADE 100 MG VIALS, a specialty pharmaceutical product, with a performance period ending on July 18, 2024. The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award, valued at $52,185.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMICADE 100 MG VIALS, a specialty medication, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award is for the delivery of REMICADE 100 MG VIALS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
- This federal contract award, valued at $1,503.66, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566947340 - REMICADE 100 MG VIALS, and has an ultimate completion date of January 16, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type. It is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite...
- This federal contract award, valued at $18,859.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMICADE 100 MG VIALS, a specialty medication, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,860.92 firm fixed-price contract is for the supply of REMICADE 100 MG VIALS, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of April 10, 2025 and was awarded on April 9, 2025. This award is associated with a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of REMICADE 100 MG VIALS, a specialty medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $6,323.22 and has an Ultimate Completion Date of September 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $47,108.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REMICADE 100 MG VIALS, a specialty medication. The contract has an ultimate completion date of July 29, 2024 and is a Firm Fixed Price agreement. This contract award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,102.52, is for the delivery of REMICADE 100 MG VIALS, a specialty medication. The contract has a firm fixed price pricing type and an ultimate completion date of March 16, 2023. This award is a part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FHM85Delivery Order
This federal contract award, valued at $19,112.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of REMICADE 100 MG VIALS. The award is a Delivery Order contract with a Firm Fixed Price pricing type. The contract has a completion date of May 31, 2024 and was awarded on May 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating it was openly competed.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 5/30/24 |